Sonnet BioTherapeutics (SONN) Misses Q4 EPS by 31c
Tweet
Share
E-mailGet Alerts SONN Hot Sheet
Join SI Premium – FREE
Sonnet BioTherapeutics (NASDAQ: SONN) reported Q4 EPS of ($0.31).
For earnings history and earnings-related data on Sonnet BioTherapeutics (SONN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Barclays Downgrades Brown Forman (BF-B) to Equalweight
- H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
